Processa Pharmaceuticals, Inc. filed a Form 8-K on October 29, 2026, disclosing that Justin Yorke resigned as chair of the board of directors on October 27, 2026, and that Dr. Sheila Gujrathi was appointed non-employee executive chair of the board effective October 28, 2026.

Key Highlights

  • Resignation: Justin Yorke resigned as chair of the board of directors on October 27, 2026, according to the filing.
  • New appointment: Dr. Sheila Gujrathi was appointed non-employee executive chair of the board, effective immediately on October 28, 2026.
  • Continued board service: The filing states that Mr. Yorke will continue as a member of the board of directors.
  • Press release issued: On October 29, 2026, the company issued a press release announcing Dr. Gujrathi's appointment and "other corporate updates," attached as Exhibit 99.1.
  • Registrant: Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), a Delaware corporation listed on The Nasdaq Stock Market LLC.

Processa Pharmaceuticals Board Leadership Change: Yorke Out as Chair, Gujrathi In

According to the Form 8-K filed October 29, 2026, under Item 8.01 (Other Events), Justin Yorke stepped down as chair of the board of directors of Processa Pharmaceuticals, Inc. on October 27, 2026. The filing notes that Mr. Yorke's resignation applied only to the chair role and that he will remain a member of the board.

The board acted the following day: on October 28, 2026, it appointed Dr. Sheila Gujrathi to the newly defined role of non-employee executive chair, with the appointment taking effect immediately, the company disclosed. The filing does not elaborate on Dr. Gujrathi's prior background or the specific duties attached to the executive chair role beyond the title itself.

The company also disclosed that it issued a press release on October 29, 2026, announcing Dr. Gujrathi's appointment as executive chair "among other corporate updates." That press release was attached to the filing as Exhibit 99.1 and incorporated by reference. The Form 8-K was signed by Russell Skibsted, Chief Financial Officer, on behalf of Processa Pharmaceuticals, Inc.

What Was Disclosed

Processa Pharmaceuticals reported the resignation of Justin Yorke as board chair on October 27, 2026, and the appointment of Dr. Sheila Gujrathi as non-employee executive chair effective October 28, 2026. Mr. Yorke remains a board member.